CI Investments Inc
CRSP icon

CI Investments Inc’s CRISPR Therapeutics CRSP Stock Holding History

CI Investments Inc’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,757
Closed -$94K – 1305
2025
Q1 		$94K Sell
2,757
-12
-0.4% -$509 ﹤0.01% 929
2024
Q4 		$109K Buy
2,769
+466
+20% +$22K ﹤0.01% 916
2024
Q3 		$108K Buy
2,303
+18
+0.8% +$913 ﹤0.01% 836
2024
Q2 		$123K Buy
2,285
+576
+34% +$33.3K ﹤0.01% 757
2024
Q1 		$116K Buy
1,709
+1
+0.1% +$72 ﹤0.01% 854
2023
Q4 		$107K Sell
1,708
-155
-8% -$8.57K ﹤0.01% 818
2023
Q3 		$85K Sell
1,863
-56
-3% -$2.89K ﹤0.01% 856
2023
Q2 		$108K Sell
1,919
-230
-11% -$13.1K ﹤0.01% 771
2023
Q1 		$97K Sell
2,149
-27
-1% -$1.31K ﹤0.01% 748
2022
Q4 		$88K Buy
2,176
+1,820
+511% +$96.5K ﹤0.01% 781
2022
Q3 		$23K Sell
356
-27
-7% -$1.96K ﹤0.01% 1005
2022
Q2 		$23K Buy
383
+14
+4% +$823 ﹤0.01% 952
2022
Q1 		$23K Buy
369
+26
+8% +$1.63K ﹤0.01% 1043
2021
Q4 		$26K Buy
343
+72
+27% +$6.29K ﹤0.01% 1068
2021
Q3 		$30K Buy
+271
New +$34K ﹤0.01% 1027

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CI Investments Inc's CRSP Position: Q2 2025 in Review

CI Investments Inc sold out of CRISPR Therapeutics (CRSP) in Q2 2025, closing a stake of 2,757 shares — an estimated $94K sold.

CI Investments Inc first reported a position in CRSP in Q3 2021 and held it in 15 quarters. The position peaked at $123K in Q2 2024. 433 funds tracked by Wall St. Rank hold CRSP as of Q2 2025.

  • CI Investments Inc reported no remaining CRISPR Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 2,757 CRISPR Therapeutics shares in Q2 2025, an estimated $94K.
  • CI Investments Inc first reported a position in CRISPR Therapeutics in Q3 2021 and held it in 15 quarters.
  • CI Investments Inc's CRISPR Therapeutics position peaked at $123K in Q2 2024.
  • 433 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.